Grace Therapeutics Inc. (GRCE) at a glance

Grace Therapeutics Inc. (GRCE) is a micro-cap Healthcare company. It trades at $2.17, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 55/100 overall. Its strongest dimension is Safety (90/100) and its weakest is Momentum (20/100). It is a relatively defensive holding with below-market volatility.

Price

$2.17

Market cap

$46.3M

P/E ratio

n/a

Dividend yield

None

Beta

0.43

52-week range

$1.79 to $5.18